Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphism
2020 ◽
Vol 67
(3.4)
◽
pp. 343-350
Sachiko Arai
◽
Shinji Takeuchi
◽
Koji Fukuda
◽
Azusa Tanimoto
◽
Akihiro Nishiyama
◽
...
Tadaaki Yamada
◽
Joseph M. Amann
◽
Azusa Tanimoto
◽
Hirokazu Taniguchi
◽
Takehito Shukuya
◽
...
2020 ◽
Vol 17
◽
pp. 448-459
Yuwen He
◽
Danyang Chen
◽
Yanmei Yi
◽
Shanshan Zeng
◽
Shuang Liu
◽
...
2018 ◽
Vol 29
(1)
◽
pp. 80-88
◽
Jun Wang
◽
Mei-qing Xu
◽
Xian-liang Jiang
◽
Xin-yu Mei
◽
Xue-gang Liu
Umamaheswari Natarajan
◽
Thiagarajan Venkatesan
◽
R Vijayaraghavan
◽
Shila Samuel
◽
Appu Rathinavelu
T WATANABE
◽
M HIOKI
◽
T FUJIWARA
◽
M NISHIZAKI
◽
S KAGAWA
◽
...
Umamaheswari Natarajan
◽
Thiagarajan Venkatesan
◽
R Vijayaraghavan
◽
Shila Samuel
◽
Appu Rathinavelu
2016 ◽
Vol 32
(6)
◽
pp. 469-482
◽
Lianmin Bao
◽
Hua Diao
◽
Nian Dong
◽
Xiaoqiong Su
◽
Bingbin Wang
◽
...
2015 ◽
Vol 94
(2)
◽
pp. 79-90
◽
Valentina Zuco
◽
Giuliana Cassinelli
◽
Giacomo Cossa
◽
Laura Gatti
◽
Enrica Favini
◽
...
Close
Export Citation Format
Close
Share Document
Close